Michael studied biochemistry at the University of Glasgow, before completing a PhD at Queen Mary University of London where he investigated how cells communicate. After that he worked in a science press office and joined Cancer Research UK’s News and Multimedia team in 2016, where he writes for the blog and news feed.
In this week’s news a drug was approved for some lung cancer patients in England, and vaping could be a big piece of the quitting smoking puzzle.
In this week’s cancer news there’s Brexit plans, viruses being used as treatments, and disagreements over screening for prostate cancer.
In this week’s cancer news there’s vitamin supplements and lung cancer risk, physical activity in middle age and immunotherapy research.
NHS behind on waiting times, childhood obesity, golden drugs showing promise, and… at-home genetic tests? Here’s our weekly news digest.
In part 4 of our radiotherapy series we look at MRI-guided radiotherapy, and how it could help improve accuracy and reduce side effects.
Too many women receiving their smear test results late, dogs on prescription, study produces map of cancer genes, and… what’s this about salmon sperm sunscreen?
We launch phase 2 of our Grand Challenge with 8 of the biggest questions in cancer research.
Smoking rates are falling, aspirin has risks as well as benefits and… what’s behind the talk of ‘tanning drugs’? Here’s our weekly news report.
Tiny fruit flies – officially called Drosophila melanogaster – have helped scientists uncover a huge amount about cancer in the lab.
How is CRISPR genome editing helping harness the power of immunotherapy?